nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—endothelium—malignant glioma	0.0414	0.149	CbGeAlD
Mimosine—CCL2—blood vessel—malignant glioma	0.0382	0.138	CbGeAlD
Mimosine—TYR—retina—malignant glioma	0.0351	0.126	CbGeAlD
Mimosine—CCL2—embryo—malignant glioma	0.0228	0.082	CbGeAlD
Mimosine—CCL2—retina—malignant glioma	0.0201	0.0725	CbGeAlD
Mimosine—CCL2—telencephalon—malignant glioma	0.0185	0.0667	CbGeAlD
Mimosine—CCL2—medulla oblongata—malignant glioma	0.0146	0.0524	CbGeAlD
Mimosine—CCL2—midbrain—malignant glioma	0.0133	0.0479	CbGeAlD
Mimosine—CCL2—spinal cord—malignant glioma	0.013	0.0468	CbGeAlD
Mimosine—SHMT1—central nervous system—malignant glioma	0.0114	0.0409	CbGeAlD
Mimosine—SHMT1—cerebellum—malignant glioma	0.0111	0.04	CbGeAlD
Mimosine—CCL2—central nervous system—malignant glioma	0.0105	0.0379	CbGeAlD
Mimosine—CCL2—cerebellum—malignant glioma	0.0103	0.0371	CbGeAlD
Mimosine—SHMT1—brain—malignant glioma	0.00902	0.0325	CbGeAlD
Mimosine—CCL2—brain—malignant glioma	0.00836	0.0301	CbGeAlD
Mimosine—CCL2—Folate Metabolism—F2—malignant glioma	0.00341	0.00473	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—CASP3—malignant glioma	0.0033	0.00458	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—PTPN11—malignant glioma	0.00325	0.0045	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—GJA1—malignant glioma	0.00319	0.00441	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IFNG—malignant glioma	0.00318	0.0044	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MMP9—malignant glioma	0.00312	0.00432	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IFNG—malignant glioma	0.00312	0.00432	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—SLC5A5—malignant glioma	0.0031	0.0043	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—STAT3—malignant glioma	0.00307	0.00425	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—STAT3—malignant glioma	0.00307	0.00425	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL1B—malignant glioma	0.00284	0.00393	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL1B—malignant glioma	0.00278	0.00385	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL2—malignant glioma	0.00277	0.00384	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CXCL8—malignant glioma	0.00274	0.0038	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCR3—malignant glioma	0.00272	0.00377	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—RTEL1—malignant glioma	0.00271	0.00376	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—F2—malignant glioma	0.00271	0.00375	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—IL1B—malignant glioma	0.00267	0.0037	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—TNF—malignant glioma	0.00266	0.00368	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—KRAS—malignant glioma	0.00264	0.00365	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—RAF1—malignant glioma	0.0026	0.00359	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IFNG—malignant glioma	0.00259	0.00358	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—BAD—malignant glioma	0.00259	0.00358	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CDKN2A—malignant glioma	0.00253	0.0035	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.00249	0.00345	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IFNG—malignant glioma	0.00247	0.00342	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00246	0.0034	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—PIK3CA—malignant glioma	0.00242	0.00336	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—PIK3CA—malignant glioma	0.00242	0.00336	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—TNF—malignant glioma	0.0024	0.00333	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—malignant glioma	0.0024	0.00332	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—CASP3—malignant glioma	0.00233	0.00323	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL1B—malignant glioma	0.00231	0.00319	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL2—malignant glioma	0.0023	0.00318	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CXCL8—malignant glioma	0.00229	0.00318	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MMP9—malignant glioma	0.00227	0.00315	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00227	0.00314	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL2—malignant glioma	0.00219	0.00304	CbGpPWpGaD
Mimosine—CCL2—Unfolded Protein Response (UPR)—CXCL8—malignant glioma	0.0021	0.00291	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MMP9—malignant glioma	0.00208	0.00287	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—PTEN—malignant glioma	0.00206	0.00286	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—TNF—malignant glioma	0.00206	0.00285	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IFNG—malignant glioma	0.00206	0.00284	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TNF—malignant glioma	0.00202	0.0028	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—VEGFA—malignant glioma	0.00198	0.00274	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—PTGS2—malignant glioma	0.00197	0.00273	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—RAF1—malignant glioma	0.00197	0.00272	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—STAT3—malignant glioma	0.00196	0.00271	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—malignant glioma	0.00188	0.0026	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR4—malignant glioma	0.00187	0.00259	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL1B—malignant glioma	0.00183	0.00254	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00183	0.00253	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—XBP1—malignant glioma	0.00181	0.00251	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT1—malignant glioma	0.00179	0.00248	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TP53—malignant glioma	0.00178	0.00247	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—CASP3—malignant glioma	0.00176	0.00244	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MYC—malignant glioma	0.00171	0.00237	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—KRAS—malignant glioma	0.00168	0.00233	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TNF—malignant glioma	0.00167	0.00232	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00167	0.00231	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IFNG—malignant glioma	0.00163	0.00225	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LATS2—malignant glioma	0.0016	0.00221	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—COX8A—malignant glioma	0.00156	0.00216	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—PTGS2—malignant glioma	0.00156	0.00216	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—malignant glioma	0.00154	0.00214	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00152	0.0021	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CXCL8—malignant glioma	0.00151	0.00209	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TP53—malignant glioma	0.00149	0.00207	CbGpPWpGaD
Mimosine—SHMT1—Disease—BCAN—malignant glioma	0.00149	0.00206	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TP53—malignant glioma	0.00148	0.00204	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—F2—malignant glioma	0.00146	0.00203	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL1B—malignant glioma	0.00145	0.00201	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CASP3—malignant glioma	0.00145	0.002	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL2—malignant glioma	0.00144	0.002	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—malignant glioma	0.00144	0.002	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TP53—malignant glioma	0.00141	0.00195	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCR3—malignant glioma	0.00139	0.00193	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MMP9—malignant glioma	0.00137	0.00189	CbGpPWpGaD
Mimosine—SHMT1—Disease—DTX1—malignant glioma	0.00135	0.00186	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—SPHK1—malignant glioma	0.00134	0.00186	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—TNF—malignant glioma	0.00133	0.00184	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ASMT—malignant glioma	0.00133	0.00184	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNF—malignant glioma	0.00128	0.00178	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—KRAS—malignant glioma	0.00127	0.00176	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—BDKRB2—malignant glioma	0.00127	0.00176	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—malignant glioma	0.00126	0.00175	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—BCAN—malignant glioma	0.00125	0.00173	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LATS1—malignant glioma	0.00121	0.00168	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—KNG1—malignant glioma	0.00116	0.0016	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MYC—malignant glioma	0.00113	0.00156	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—EGFR—malignant glioma	0.0011	0.00153	CbGpPWpGaD
Mimosine—SHMT1—Disease—HEY2—malignant glioma	0.00106	0.00146	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TNF—malignant glioma	0.00105	0.00146	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00103	0.00143	CbGpPWpGaD
Mimosine—SHMT1—Disease—IDH1—malignant glioma	0.00103	0.00143	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—IDH2—malignant glioma	0.001	0.00139	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—MYC—malignant glioma	0.000996	0.00138	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000983	0.00136	CbGpPWpGaD
Mimosine—SHMT1—Disease—HEY1—malignant glioma	0.000978	0.00135	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR4—malignant glioma	0.000961	0.00133	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—malignant glioma	0.000956	0.00132	CbGpPWpGaD
Mimosine—SHMT1—Disease—HIST1H3B—malignant glioma	0.00095	0.00132	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2B6—malignant glioma	0.000945	0.00131	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—BCHE—malignant glioma	0.000928	0.00128	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—malignant glioma	0.000927	0.00128	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—FBXW7—malignant glioma	0.000913	0.00126	CbGpPWpGaD
Mimosine—SHMT1—Disease—JAG2—malignant glioma	0.000867	0.0012	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—IDH1—malignant glioma	0.000864	0.0012	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SPHK1—malignant glioma	0.000836	0.00116	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2C18—malignant glioma	0.000819	0.00113	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MDK—malignant glioma	0.000819	0.00113	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DTX1—malignant glioma	0.000781	0.00108	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—F2—malignant glioma	0.000748	0.00104	CbGpPWpGaD
Mimosine—SHMT1—Disease—H3F3A—malignant glioma	0.000734	0.00102	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCR3—malignant glioma	0.000714	0.000988	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000692	0.000959	CbGpPWpGaD
Mimosine—SHMT1—Disease—JAG1—malignant glioma	0.000692	0.000958	CbGpPWpGaD
Mimosine—SHMT1—Disease—FBXW7—malignant glioma	0.000678	0.000938	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTT1—malignant glioma	0.000662	0.000917	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—BDKRB2—malignant glioma	0.000653	0.000904	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTGS1—malignant glioma	0.000621	0.000859	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SUFU—malignant glioma	0.00062	0.000859	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HEY2—malignant glioma	0.000613	0.000848	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GFAP—malignant glioma	0.000599	0.000829	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KNG1—malignant glioma	0.000594	0.000822	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SPHK1—malignant glioma	0.000579	0.000802	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—BCHE—malignant glioma	0.000577	0.000799	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC5A5—malignant glioma	0.00057	0.000789	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR4—malignant glioma	0.000568	0.000786	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HEY1—malignant glioma	0.000568	0.000786	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HIST1H3B—malignant glioma	0.000551	0.000763	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDKN2B—malignant glioma	0.000531	0.000735	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL8—malignant glioma	0.000527	0.00073	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MMP3—malignant glioma	0.000526	0.000729	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—F2—malignant glioma	0.000526	0.000729	CbGpPWpGaD
Mimosine—SHMT1—Disease—HES1—malignant glioma	0.000507	0.000701	CbGpPWpGaD
Mimosine—SHMT1—Disease—NCOR1—malignant glioma	0.000504	0.000697	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JAG2—malignant glioma	0.000503	0.000697	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFRA—malignant glioma	0.000482	0.000668	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTP1—malignant glioma	0.000459	0.000636	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CAT—malignant glioma	0.000447	0.000619	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MMP2—malignant glioma	0.000446	0.000618	CbGpPWpGaD
Mimosine—SHMT1—Disease—TERT—malignant glioma	0.000444	0.000615	CbGpPWpGaD
Mimosine—SHMT1—Disease—HLA-A—malignant glioma	0.000444	0.000615	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFB—malignant glioma	0.000433	0.0006	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGFR1—malignant glioma	0.000431	0.000597	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—H3F3A—malignant glioma	0.000426	0.00059	CbGpPWpGaD
Mimosine—SHMT1—Disease—HIF1A—malignant glioma	0.000425	0.000588	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NCOR1—malignant glioma	0.000422	0.000584	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCR3—malignant glioma	0.000422	0.000584	CbGpPWpGaD
Mimosine—SHMT1—Disease—CAV1—malignant glioma	0.000411	0.000569	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—YWHAE—malignant glioma	0.00041	0.000568	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTRK2—malignant glioma	0.00041	0.000568	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FLT1—malignant glioma	0.000408	0.000565	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DUSP6—malignant glioma	0.000407	0.000563	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JAG1—malignant glioma	0.000402	0.000556	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOTCH3—malignant glioma	0.0004	0.000554	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FBXW7—malignant glioma	0.000393	0.000545	CbGpPWpGaD
Mimosine—SHMT1—Disease—BAD—malignant glioma	0.000386	0.000535	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BDKRB2—malignant glioma	0.000386	0.000534	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—F2—malignant glioma	0.000384	0.000532	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOTCH1—malignant glioma	0.000383	0.00053	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD80—malignant glioma	0.000375	0.000519	CbGpPWpGaD
Mimosine—SHMT1—Disease—APC—malignant glioma	0.000374	0.000518	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CXCL8—malignant glioma	0.000371	0.000513	CbGpPWpGaD
Mimosine—SHMT1—Disease—EGF—malignant glioma	0.00037	0.000512	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTPN11—malignant glioma	0.000368	0.000509	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CG—malignant glioma	0.000367	0.000509	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTPN11—malignant glioma	0.000361	0.0005	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOTCH2—malignant glioma	0.000359	0.000496	CbGpPWpGaD
Mimosine—SHMT1—Disease—BRAF—malignant glioma	0.000352	0.000487	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KNG1—malignant glioma	0.000351	0.000486	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CAV1—malignant glioma	0.000344	0.000476	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT2—malignant glioma	0.000342	0.000474	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT2—malignant glioma	0.000336	0.000465	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTRK1—malignant glioma	0.000334	0.000463	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CD—malignant glioma	0.000329	0.000455	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CD—malignant glioma	0.000323	0.000447	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF2—malignant glioma	0.000315	0.000436	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CG—malignant glioma	0.000313	0.000434	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP3—malignant glioma	0.000311	0.00043	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDKN2B—malignant glioma	0.000308	0.000427	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPARG—malignant glioma	0.000302	0.000419	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTK2—malignant glioma	0.000299	0.000414	CbGpPWpGaD
Mimosine—SHMT1—Disease—MDM2—malignant glioma	0.000295	0.000408	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HES1—malignant glioma	0.000294	0.000407	CbGpPWpGaD
Mimosine—SHMT1—Disease—RAF1—malignant glioma	0.000294	0.000406	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NCOR1—malignant glioma	0.000292	0.000405	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERBB2—malignant glioma	0.00029	0.000402	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—RAF1—malignant glioma	0.000288	0.000399	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CB—malignant glioma	0.000287	0.000397	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTGS2—malignant glioma	0.000284	0.000393	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CB—malignant glioma	0.000282	0.00039	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFRA—malignant glioma	0.00028	0.000388	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CD—malignant glioma	0.000275	0.000381	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SPP1—malignant glioma	0.000272	0.000376	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL8—malignant glioma	0.000271	0.000375	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2—malignant glioma	0.000259	0.000358	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TERT—malignant glioma	0.000258	0.000357	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFB—malignant glioma	0.000251	0.000348	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGFR1—malignant glioma	0.00025	0.000346	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTEN—malignant glioma	0.000248	0.000343	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HIF1A—malignant glioma	0.000246	0.000341	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CB—malignant glioma	0.00024	0.000332	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CAV1—malignant glioma	0.000238	0.00033	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTGS2—malignant glioma	0.000238	0.000329	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KDR—malignant glioma	0.000236	0.000326	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—F2—malignant glioma	0.000227	0.000314	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FN1—malignant glioma	0.000227	0.000314	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BAD—malignant glioma	0.000224	0.00031	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOTCH1—malignant glioma	0.000222	0.000307	CbGpPWpGaD
Mimosine—SHMT1—Disease—STAT3—malignant glioma	0.000222	0.000307	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CD80—malignant glioma	0.000217	0.000301	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CG—malignant glioma	0.000217	0.000301	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APC—malignant glioma	0.000217	0.000301	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EGF—malignant glioma	0.000215	0.000297	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTPN11—malignant glioma	0.000213	0.000295	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTEN—malignant glioma	0.000207	0.000287	CbGpPWpGaD
Mimosine—SHMT1—Disease—MYC—malignant glioma	0.000206	0.000285	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BRAF—malignant glioma	0.000204	0.000282	CbGpPWpGaD
Mimosine—SHMT1—Disease—EGFR—malignant glioma	0.000201	0.000279	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT2—malignant glioma	0.000199	0.000275	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—EGFR—malignant glioma	0.000198	0.000274	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CD—malignant glioma	0.000191	0.000264	CbGpPWpGaD
Mimosine—SHMT1—Disease—KRAS—malignant glioma	0.00019	0.000263	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KRAS—malignant glioma	0.000187	0.000259	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF2—malignant glioma	0.000183	0.000253	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CA—malignant glioma	0.000175	0.000242	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CA—malignant glioma	0.000172	0.000238	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MDM2—malignant glioma	0.000171	0.000237	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RAF1—malignant glioma	0.00017	0.000236	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB2—malignant glioma	0.000169	0.000233	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CB—malignant glioma	0.000166	0.00023	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL8—malignant glioma	0.00016	0.000221	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP3—malignant glioma	0.000153	0.000212	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2—malignant glioma	0.000153	0.000211	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CA—malignant glioma	0.000146	0.000203	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP9—malignant glioma	0.000145	0.0002	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTEN—malignant glioma	0.000144	0.000199	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—malignant glioma	0.000143	0.000198	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—malignant glioma	0.00014	0.000194	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—malignant glioma	0.00013	0.00018	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT3—malignant glioma	0.000129	0.000178	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—malignant glioma	0.00012	0.000166	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MYC—malignant glioma	0.000119	0.000165	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EGFR—malignant glioma	0.000117	0.000162	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KRAS—malignant glioma	0.00011	0.000153	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CA—malignant glioma	0.000101	0.00014	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—malignant glioma	9.81e-05	0.000136	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—malignant glioma	8.28e-05	0.000115	CbGpPWpGaD
